Kindstar Globalgene files HKEX next-day disclosure return on share buybackPUBT·Sep 11 at 11:41 AM09960-0.54%
Kindstar Globalgene files HKEX next-day disclosure return on share buyback for treasury sharesPUBT·Sep 10 at 12:10 PM09960-0.54%
Kindstar Globalgene files HKEX next-day disclosure return reporting share buybackPUBT·Sep 9 at 01:33 PM09960-0.54%
HKEX IPO Surge Masks Deepening Struggles at Central China ManagementGlobal Report·Sep 8 at 10:18 AM099820.00%01705+1.13%
Kindstar Globalgene files HKEX next-day disclosure return reporting share buyback at HKD 0.94 average pricePUBT·Sep 7 at 12:51 PM09960-0.54%
Kindstar Globalgene files HKEX next-day disclosure return on share repurchasePUBT·Sep 3 at 11:42 AM09960-0.54%
Kindstar Globalgene files HKEX next-day disclosure return on share buyback cancellationPUBT·Sep 2 at 12:29 PM09960-0.54%
Kindstar Globalgene files HKEX next-day return disclosing share buyback cancellationPUBT·Sep 1 at 11:28 AM09960-0.54%
Kindstar Globalgene files HKEX next-day disclosure after share buyback for cancellationPUBT·Aug 31 at 11:37 AM09960-0.54%
Kindstar Globalgene files HKEX next-day return disclosing share repurchase for treasury sharesPUBT·Aug 28 at 12:53 PM09960-0.54%023990.00%
Kindstar Globalgene Narrows Loss as Oncology Testing Drives Interim GrowthTip Ranks·Aug 26 at 10:37 PM09960-0.54%
Kindstar Globalgene FY26 H1 net loss narrows 44.7% to RMB 18.1 million; revenue rises 3.7% to RMB 473.6 millionPUBT·Aug 26 at 10:20 PM09960-0.54%
Kindstar Global gains 1% on continued share buyback activityHK Stock Market Update·Aug 7 at 01:50 AM09960-0.54%